Jean Benjoya

We don’t have enough information about this author to calculate their statistics. If you think this is an error let us know.
Learn More
In 2012, the European Medicines Agency published guidelines for good pharmacovigilance practices. Within these guidelines, the Agency advised that marketing authorization holders (MAHs) establish safety signal tracking systems that capture outcomes related to signals that have been validated. Historically, MAHs have collected data and information to(More)
  • 1